Brind.

Cocrystal Pharma appointed James Martin as CFO and co-CEO on September 3, 2025.

3 reports, 3 independent Updated Jul 9
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Cocrystal Pharma appointed James Martin as CFO and co-CEO on September 3, 2025.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • baystreet.ca
  • GlobeNewswireCocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Compa
  • Insider MonkeySymbotic Unveals Transition Plan For Its New CFO Symbotic Inc. (NASDAQ:SYM) is one of the 10 Best Small Cap Robotics Stocks to Buy Now. On June 9, the company unveiled its transition plan for its new